Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IDH1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
IDH1 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, associated with, implicated in. Associated with AD, ADH, ALI. Connected to 251 entities in the SciDEX knowledge graph.
| Gene Symbol | IDH1 |
| Full Name | Isocitrate Dehydrogenase 1 (NADP+) |
| Aliases | Page for IDH1 Gene, Page for IDH1 Protein |
| Chromosome | 2q33.3 |
| Protein Type | Enzyme |
| Function | IDH1 is a NADP+-dependent enzyme localized primarily in the cytosol and peroxisomes. |
| Molecular Weight | 47 kDa |
| Pathways | Epigenetic |
| UniProt ID | O75874 |
| NCBI Gene ID | 3417 |
| Ensembl ID | ENSG00000138449 |
| GeneCards | IDH1 |
| Human Protein Atlas | IDH1 |
| Associated Diseases | AD, ADH, ALI, AMI, ARM, Aging |
| Interactions | MTOR, IDH2, VHL, MDM4, MCL1, VEGFA |
| KG Connections | 388 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
IDH1["IDH1<br/>(Isocitrate Dehydrogenase 1)"]
MetabolicChanges["Metabolic<br/>Changes"]
AlphaKG["alpha-Ketoglutarate<br/>Production"]
TwoHG["2-Hydroxyglutarate<br/>(Oncometabolite)"]
Neuroinflammation["Neuroinflammation"]
Inflammation["Systemic<br/>Inflammation"]
OxidativeStress["Oxidative<br/>Stress"]
Alzheimer["Alzheimer's<br/>Disease"]
Parkinson["Parkinson's<br/>Disease"]
ALS["Amyotrophic Lateral<br/>Sclerosis"]
MS["Multiple<br/>Sclerosis"]
Neurodegeneration["Neurodegeneration"]
Glioma["Glioma"]
Glioblastoma["Glioblastoma"]
Cancer["Cancer"]
TherapeuticTarget["Therapeutic<br/>Target"]
Biomarker["Disease<br/>Biomarker"]
IDH1 --|"modulates"|--> MetabolicChanges
IDH1 --|"produces"|--> AlphaKG
IDH1 --|"mutation produces"|--> TwoHG
MetabolicChanges --|"leads to"|--> OxidativeStress
TwoHG --|"promotes"|--> Neuroinflammation
IDH1 --|"activates"|--> Neuroinflammation
IDH1 --|"activates"|--> Inflammation
Neuroinflammation --|"contributes to"|--> Neurodegeneration
IDH1 --|"activates"|--> Alzheimer
IDH1 --|"activates"|--> Parkinson
IDH1 --|"associated with"|--> ALS
IDH1 --|"associated with"|--> MS
IDH1 --|"associated with"|--> Glioma
IDH1 --|"associated with"|--> Glioblastoma
IDH1 --|"therapeutic target"|--> Cancer
IDH1 --|"serves as"|--> Biomarker
IDH1 --|"serves as"|--> TherapeuticTarget
style IDH1 fill:#006494
style AlphaKG fill:#1b5e20
style TwoHG fill:#ef5350
style Neuroinflammation fill:#ef5350
style Inflammation fill:#ef5350
style OxidativeStress fill:#ef5350
style Neurodegeneration fill:#5d4400
style Alzheimer fill:#5d4400
style Parkinson fill:#5d4400
style ALS fill:#5d4400
style MS fill:#5d4400
style TherapeuticTarget fill:#1b5e20
style Biomarker fill:#4a1a6b| Target | Relation | Type | Str |
|---|---|---|---|
| ASTROCYTOMA | associated_with | entity | 0.98 |
| OLIGODENDROGLIOMA | associated_with | entity | 0.98 |
| Isocitrate to α-Ketoglutarate Conversion | catalyzes | process | 0.98 |
| GLIOMA | associated_with | entity | 0.98 |
| GLIOBLASTOMA | associated_with | entity | 0.98 |
| ENZYMATIC ACTIVITY | regulates | entity | 0.95 |
| ALPHA-KETOGLUTARATE | associated_with | entity | 0.95 |
| Isocitrate To α-Ketoglutarate Conversion | catalyzes | process | 0.95 |
| Isocitrate | associated_with | compound | 0.95 |
| Astrocytoma | associated_with | disease | 0.95 |
| Oligodendroglioma | associated_with | disease | 0.95 |
| Nadp+-Dependent Isocitrate Dehydrogenase | involved_in | enzyme | 0.92 |
| alpha-ketoglutarate | catalyzes | entity | 0.90 |
| alpha-KG-dependent dioxygenases | inhibits | enzyme | 0.90 |
| BRAIN TUMOURS | associated_with | entity | 0.90 |
| Secondary Glioblastoma | associated_with | disease | 0.90 |
| NADPH | catalyzes | entity | 0.90 |
| NADPH | associated_with | entity | 0.90 |
| NADH | associated_with | entity | 0.90 |
| GLIOMA | mutated_in | disease | 0.90 |
| gliomas | associated_with | disease | 0.90 |
| IDH2 | interacts_with | entity | 0.85 |
| REDOX BALANCE | associated_with | entity | 0.85 |
| ORGAN PHYSIOLOGY | regulates | entity | 0.85 |
| Gene Expression | regulates | process | 0.85 |
| Patient Survival | protects_against | phenotype | 0.85 |
| gene expression | associated_with | process | 0.85 |
| glioma prognosis | associated_with | phenotype | 0.85 |
| malignancy | contributes_to | phenotype | 0.80 |
| PSAT1 | upregulates | gene | 0.80 |
| serine biosynthesis | activates | biological_process | 0.80 |
| KDM4A | upregulates | gene | 0.80 |
| KDM4B | upregulates | gene | 0.80 |
| KDM4C | upregulates | gene | 0.80 |
| Metabolic Rewiring | involved_in | process | 0.80 |
| PHGDH | upregulates | gene | 0.80 |
| NEURODEGENERATION | associated_with | entity | 0.80 |
| MTOR Pathway Activity | associated_with | process | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Carcinoma | therapeutic_target | disease | 0.75 |
| Tumor | therapeutic_target | disease | 0.75 |
| mTOR | activates | protein | 0.75 |
| Neurodegeneration | contributes_to | disease | 0.75 |
| metabolic changes | regulates | process | 0.70 |
| DNA | therapeutic_target | gene | 0.70 |
| GENES | therapeutic_target | gene | 0.70 |
| Epigenetic | associated_with | pathway | 0.70 |
| glioblastoma | associated_with | disease | 0.70 |
| MTOR | activates | protein | 0.66 |
| Glioblastoma | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SF3B1 | therapeutic_target | gene | 0.60 |
| TERT | therapeutic_target | gene | 0.60 |
| SMARCA4 | therapeutic_target | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| BRAF | associated_with | gene | 0.60 |
| TERT | associated_with | gene | 0.60 |
| FUBP1 | associated_with | gene | 0.60 |
| H3F3A | associated_with | gene | 0.60 |
| JUN | biomarker_for | gene | 0.60 |
| STK11 | contributes_to | gene | 0.60 |
| PTEN | contributes_to | gene | 0.60 |
| PI3K | contributes_to | gene | 0.60 |
| APOB | associated_with | gene | 0.60 |
| EEF1A1 | associated_with | gene | 0.60 |
| ATRX | associated_with | gene | 0.60 |
| CIC | associated_with | gene | 0.60 |
| AKT | contributes_to | gene | 0.60 |
| CDK4 | associated_with | gene | 0.60 |
| TEAD1 | therapeutic_target | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| FGFR3 | associated_with | gene | 0.60 |
| NF1 | associated_with | gene | 0.60 |
| CD47 | therapeutic_target | gene | 0.60 |
| CD33 | therapeutic_target | gene | 0.60 |
| NPM1 | associated_with | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| TET2 | associated_with | gene | 0.60 |
| DNMT3A | associated_with | gene | 0.60 |
| NRAS | associated_with | gene | 0.60 |
| LGALS3 | expressed_in | gene | 0.60 |
| KCNH2 | therapeutic_target | gene | 0.60 |
| PIK3CA | associated_with | gene | 0.60 |
| IDH2 | inhibits | gene | 0.60 |
| EEF1A1 | inhibits | gene | 0.60 |
| MDM4 | inhibits | gene | 0.60 |
| JUN | inhibits | gene | 0.60 |
| MET | inhibits | gene | 0.60 |
| MCL1 | inhibits | gene | 0.60 |
| VEGFA | inhibits | gene | 0.60 |
| SMARCA4 | inhibits | gene | 0.60 |
| SF3B1 | inhibits | gene | 0.60 |
| APOB | inhibits | gene | 0.60 |
| TERT | inhibits | gene | 0.60 |
| IDH2 | associated_with | gene | 0.60 |
| OVERVIEW | biomarker_for | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| VHL | activates | gene | 0.60 |
| PTEN | implicated_in | gene | 0.60 |
| TP53 | therapeutic_target | gene | 0.60 |
| CALM1 | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-13 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||